Literature DB >> 6687769

Effect of cyclosporine on experimental autoimmune thyroiditis in mice.

A O Vladutiu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687769

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.

Authors:  H C Gunn; B Ryffel
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

2.  The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c rat.

Authors:  R A Hassman; C Dieguez; D P Rennie; A P Weetman; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  The anti-arthritic and immunosuppressive effects of cyclosporine on arthritis induced in the rat by type II collagen.

Authors:  B Henderson; N A Staines; I Burrai; J H Cox
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse.

Authors:  L Jansson; S Sandler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 6.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10

7.  Pathogenetic difference between collagen arthritis and adjuvant arthritis.

Authors:  N Kaibara; T Hotokebuchi; K Takagishi; I Katsuki; M Morinaga; C Arita; S Jingushi
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.